Change the World
IlluminaRANK20
Long at the forefront of gene-sequencing and -therapy technology, Illumina is picking up steam thanks to the proliferation of DNA sequencing across a variety of medical applications—including tracking infectious diseases like COVID-19. Illumina says there are now some 70 countries using its tech to monitor and analyze samples of the coronavirus, hoping to track how it could mutate into variants. Just as Illumina has helped sharply reduce the cost of genetic sequencing, it aims to do the same for cancer diagnostics via its acquisition of biotech Grail (though the deal faces scrutiny from antitrust regulators).
Courtesy of Illumina
Latest news for Illumina
- TechThera-who? These biotech firms are looking to push what’s possible with bloodOctober 22, 2021 6:00 PM UTC
- NewslettersAnother COVID booster unknown: Will more doses for the vaccinated cause new variants?August 19, 2021 10:31 PM UTC
- CommentaryCommentary: Attacking Biology’s Complexity with New Genomics ApproachesJanuary 8, 2019 9:17 PM UTC